Skip to main content

ASP Isotopes Announces Establishment of Quantum Leap Energy Strategic Advisory Board, Bolstering its Plans for the Nuclear Fuel Sector

Distinguished Nuclear Fuel and Advanced Materials Leaders Appointed as Initial SAB Members DALLAS, Feb. 19, 2026 (GLOBE NEWSWIRE) — ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) today announced that Quantum Leap Energy LLC (“QLE” or the “Company”), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, has formed a Strategic Advisory Board (“SAB)”, and appointed, as initial SAB members, two distinguished nuclear fuel and advanced materials industry leaders: Mary Lou Dunzik-Gougar and Kevin Kramer. The SAB is expected to provide guidance and insights as QLE aims to address gaps in the nuclear fuel cycle, promote safe nuclear power, and enhance the sustainability of the nuclear fuel cycle for advanced nuclear reactors, fusion...

Continue reading

Moleculin Announces Exercise of Warrants for $8.3 Million Gross Proceeds

HOUSTON, Feb. 19, 2026 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced it has entered into agreements with certain holders of its existing warrants for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 2,122,652 shares of common stock of the Company at an exercise price of $3.90 per share. The issuance or resale of the shares of common stock issuable upon exercise of the outstanding warrants has been registered pursuant to effective registration statements. The aggregate gross proceeds from the exercise of the existing warrants is expected to total approximately $8.3 million, before deducting financial advisory fees. Roth Capital Partners is acting as the Company’s financial advisor for this transaction. In consideration for the immediate...

Continue reading

Getty Images issues statement on CMA’s interim report

NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) — Getty Images (NYSE: GETY), a preeminent global visual content creator and marketplace, today issued the following statement on the UK Competition and Markets Authority’s (CMA) provisional decision: “We are pleased to see the CMA’s progress with respect to the proposed merger between Getty Images and Shutterstock, particularly its provisional finding that the merger is not expected to result in competition issues in the global Stock content market. We are disappointed and disagree with the CMA’s provisional finding that the merger may result in a ‘substantial lessening of competition’ in the UK Editorial market. We do not believe the analysis or interim conclusions reflect the composition of the UK market, the level of regional competition within it or the alternatives available to customers. We...

Continue reading

ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026

SOUTH SAN FRANCISCO, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc. (“ALX Oncology”; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today announced that ALX Oncology leadership will participate in the Wells Fargo Executive Biotech Summit, TD Cowen 46th Annual Health Care Conference, and UBS Biotech Summit. The details of the meetings are as follows: Wells Fargo Executive Biotech Summit Format: One-on-one meetingsDate: February 24-25, 2026Location: Lake Tahoe, CA TD Cowen 46th Annual Health Care Conference Format: PresentationDate: March 3, 2026Time: 9:10 AM ESTLocation: Boston, MAWebcast link: Available here UBS Biotech Summit Format: One-on-one meetingsDate: March 10, 2026Location: Miami, FL The webcast...

Continue reading

Autonomix Medical Selected to Present New Long-Term Pain Mitigation Data in Pancreatic Cancer at SSO 2026 Annual Meeting in Podium Presentation

THE WOODLANDS, TX, Feb. 19, 2026 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that Clarke Wilkirson, PhD, Clinical Development Engineer II, will present new long-term clinical data at the Society of Surgical Oncology (SSO) 2026 Annual Meeting, happening March 5-7, 2026, in Phoenix, Arizona. The presentation, titled “Pain Mitigation in Pancreatic Adenocarcinoma: A Long-Term Analysis of Denervation via Transvascular RF Energy-Based Ablation” (Submission ID: 2249416), has been accepted as an oral podium presentation. Dr. Wilkirson will deliver a five-minute presentation followed by a two-minute question-and-answer session, highlighting the potential of Autonomix Medical’s minimally invasive...

Continue reading

INVO Fertility Closes Acquisition of Indiana-Based Fertility Clinic “Family Beginnings”

Strategic Transaction Advances Company’s Growth SARASOTA, Fla., Feb. 19, 2026 (GLOBE NEWSWIRE) — INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced that it has successfully closed the previously announced acquisition of Family Beginnings, P.C., a respected fertility clinic serving patients across Indiana and the broader Midwest. The transaction was completed in accordance with the terms of the definitive purchase agreement first announced on December 17, 2025. Founded more than a decade ago, Family Beginnings has built a strong reputation for delivering comprehensive fertility services with a highly personalized, patient-first approach. The clinic offers...

Continue reading

Talkspace Announces Fourth Quarter and Full Year 2025 Results

4Q 2025 total revenue grew 29% year-over-year to $63.0 million4Q 2025 net income of $4.8 million and adjusted EBITDA1 of $6.6 million Full-year 2025 total revenue grew 22% year-over-year to $228.9 millionFull-year 2025 net income of $7.8 millionFull-year 2025 adjusted EBITDA1 grew 127% year-over-year to $15.8 million NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) — Talkspace, Inc. (“Talkspace” or the “Company”) (NASDAQ: TALK), today reported fourth quarter and full year 2025 financial results.    Three Months EndedDecember 31,   Year EndedDecember 31,      2025   2024   2025   2024      Results   % Variancefrom PriorYear   Results   % Variancefrom PriorYear  (In thousands unless otherwise noted) Unaudited   Unaudited    Number of completed Payor sessions   449.7     36 %     1,617.0     32 %  Number...

Continue reading

MediWound to Report Fourth Quarter and Full Year 2025 Financial Results

MediWound to Report Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast Scheduled for Thursday, March 5th at 8:30 a.m. Eastern Time YAVNE, Israel, February 19, 2026 — MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2025 on Thursday, March 5, 2026. Following the release, MediWound’s management will host a conference call and live webcast at 8:30 a.m. Eastern Time to discuss the financial results and provide business highlights. Conference Call & Webcast Details Toll-Free:                1-844-676-8833Israel:                        1-80-921-2373 International:                1-412-634-6869Webcast:                Click HERE To access...

Continue reading

EpicQuest Education Enters into Agreement to Offer its Graduate Foundational and Masters of Science in Management Programs Globally

The Agreement Represents a Strategic Expansion into High Growth Markets with the Potential to Generate Substantial Revenue over the Next Three Years TOLEDO, Ohio, Feb. 19, 2026 (GLOBE NEWSWIRE) — EpicQuest Education Group International Limited (Nasdaq: EEIQ), (“EpicQuest Education”, “EEIQ” or the “Company”), a provider of higher education for domestic and international students in the US, Canada and the UK,  today announced that Davis University (“Davis”) recently entered into an Agency Agreement (the “Agreement”) with Veritas Global Uni (Pvt) Ltd. (“Veritas”) for it to be a non-exclusive recruitment agent for Davis’ online Masters of Science in Management Program and its Graduate Foundational Program. “The Agreement enables students from diverse regions to overcome the high cost of higher education and earn a valuable graduate...

Continue reading

TransUnion 2026 Originations Forecast Shows Continued Positive Momentum Amidst Moderate Expansion

Findings released in conjunction with TransUnion’s Q4 2025 Credit Industry Insights Report CHICAGO, Feb. 19, 2026 (GLOBE NEWSWIRE) — TransUnion (NYSE: TRU) released its 2026 credit originations forecast, highlighting continued momentum in originations for mortgages as well as for unsecured personal loans. These growth trends come as forecasted demand for other credit products shows mixed performance. TransUnion released the originations forecast alongside its Q4 2025 Credit Industry Insights Report (CIIR), which pointed to continued expansion in consumer lending at the end of 2025. The 2026 originations forecast points to mortgage and unsecured personal loans as the primary drivers of projected expansion. Mortgage originations, both purchase and refinance, are set to extend the rebound of the past two years from near-record low...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.